Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 9, 2024. The filing includes a presentation related to the company's business and operations, which will be made available on the same day. This presentation is part of a Regulation FD disclosure and can be accessed through the Investors section of the company's website. Intelligent Bio Solutions has been identified as an emerging growth company and has furnished this information under Item 7.01 of the report, which is not to be considered 'filed' for purposes of the Exchange Act nor incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, unless specifically stated. The company's Chief Financial Officer, Spiro Sakiris, has signed off on the report.

Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 9, 2024. The filing includes a presentation related to the company's business and operations, which will be made available on the same day. This presentation is part of a Regulation FD disclosure and can be accessed through the Investors section of the company's website. Intelligent Bio Solutions has been identified as an emerging growth company and has furnished this information under Item 7.01 of the report, which is not to be considered 'filed' for purposes of the Exchange Act nor incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, unless specifically stated. The company's Chief Financial Officer, Spiro Sakiris, has signed off on the report.